Oxford Bioelectronics is developing a non-invasive peripheral nerve stimulation device for Dry Age-related Macular Degeneration (AMD)
Oxford Bioelectronics is developing a non-invasive peripheral nerve stimulation device for Dry Age-related Macular Degeneration (AMD). Their technology aims to improve blood flow, reduce inflammation, and promote the growth of nerve cells, with clinical studies planned to test its efficacy as a treatment for Dry AMD.